Table 2.
IFNγ | TNFα | IL-2 | IL-4 | IL-5 | |
---|---|---|---|---|---|
Mock | 0.0+/−0.0 | 34.4+/−27.0 | 0.7+/−0.8 | 1.4+/−0.3 | 2.3+/−0.5 |
VACVΔE3L(WR) | 13776.1+/−1208.3 | 556.7+/−118.3 | 161.9+/−23.8 | 38.1+/−9.8 | 27.7+/−11.2 |
VACV-vIF2αH(WR) | 11508.8+/−2383.7 | 505.8+/−155.4 | 100.4+/−36.9 | 33.4+/−5.1 | 16.5+/−11.5 |
VACVE3LΔ54N(WR) | 13069.7+/−2474.6 | 532.8+/−31.9 | 72.7+/− 45.6 | 44.4+/−3.4 | 32.1+/−6.9 |
VACVE3LΔ7C(WR) | 9841.6+/−3594.4 | 499.6+/−180.4 | 76.2+/−19.6 | 96.9+/−37.2 | 17.3+/−20.2 |
wtVACV(WR) | 6746.8+/−634.3 | 252.9+/−44.8 | 58.1+/−22.2 | 83.0+/−18.0 | 26.8+/−8.5 |
VACVÄE3L(NYCBH) | 17159.0+/−4926.8 | 725.3+/−188.8 | 144.3+/−84.7 | NT* | NT |
wtVACV(NYCBH) | 11204.4+/−2143.7 | 960.2+/−259.7 | 96.8+/−26.8 | NT | NT |
Not tested